We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is an ISO 9001:2015 certified provider of Pan-European reimbursement services and products for Med Tech and IVD industry

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

Scope

Coding, payment mechanism, reimbursement tariffs, pathway to create or improve reimbursement situation

 

Project-based on-demand work or >95 off-the-shelf syndicated reports

Countries
19 EU
Availability
Mixed
Scope

Seminars on introduction into market access for medical devices and IVD tests, seminars on reimbursement systems in individual countries (>70 reports)

 

Syndicated analytical reports on the topics of HTA, innovation funding, reimbursement of health apps

Countries
19 EU
Availability
Off-the-shelf
Scope

Subscription service with email alerts about initiated or published health technology assessments and reimbursement decisions for medical devices and in-vitro diagnostic tests from reimbursement (EU) and HTA (global) organizations

Countries
24 countries globally
Availability
On-demand
Scope

Procedure code and DRG change applications in the Nordic region

Countries
Nordics
Availability
On-demand
Scope

A fact-based, unbiased approach to determine clinical and economic evidence requirements on the basis of the benchmarking to the prevision reimbursement decisions of reimbursement authorities and HTA organizations

Countries
14 EU
Availability
On-demand

Why us?

Analyses from the same vendor for 19 different EU countries
Analyses from the same vendor for 19 different EU countries

Save money and time, get standardized analysis. One of the broadest coverage of EU markets. Our key value proposition is provision of high quality pan-European support

Pharma approach is put aside
Pharma approach is put aside

Work with a company truly specialized in medical devices and diagnostics. Benefit from our topical knowledge from hundreds of projects

Getting results instantly (reports) or within 4-8 weeks (services)
Getting results instantly (reports) or within 4-8 weeks (services)

Make business decisions quickly

17 out of top-30 companies choose MTRC for reimbursement support
17 out of top-30 companies choose MTRC for reimbursement support

Work with a provider who understands the industry’s needs. We served more than 150 clients over the last four years

More than 540 accomplished projects
More than 540 accomplished projects

Work with a provider who has experience in your field. We are ISO 9001:2015 certified and pay a lot of attention to maintain a good quality of services, including >300 internal instructions, regular quality management meetings, strict onboarding and training procedures

Team of 15 full-time employees in 6 countries
Team of 15 full-time employees in 6 countries

Unlike companies with an affiliate model, we do most services with in-house analysts ensuring greater quality, lower cost and predictable outcomes

MTRC is a thought leader in the field of European Med Tech reimbursement
MTRC is a thought leader in the field of European Med Tech reimbursement

MTRC has unique insights into market access through its various activities, including annual syndicated reports on the topics of HTA, innovation funding, reimbursement of digital health, comprehensive newsletter services, unparalleled educational platform and others

To stay up-to-date, we daily monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get updates every 2nd week

Only less than 10% of the news is reported in the free-of-charge newsletter. Access our paid services "HTA Alerts" and "Reimbursement Alerts" to get full, customized reports from more than 90 reimbursement and HTA organizations globally. Free first issues of both newsletters are available for download

04 Oct 2022
A value dossier is a document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The unique approach of MTRC is based on a deep understanding of evidence and data presentation requirements for market access processes in a large number of European countries.

02

Dec 2022

On November 15, 2022, a new body called “Organization for Outpatient Physician Tariffs AG (OAAT)” was founded under the leadership of the Bernese government councillor. It involves all tariff partners (associations of health insurers curafutura and santésuisse, as well as the association of hospitals H+, the association of physicians FMH, and medical tariff commission MTK/CTM), who have joined forces in order to reach the goal of improving the outpatient reimbursement system.

01

Dec 2022

In November 2022, NHS Accelerated Access Collaborative decided not to add new technologies to MedTech Funding Mandate (MTFM) in 2023/24. Instead, Integrated Care Systems (ICSs) are asked to prioritize the appropriate adoption of currently supported technologies where this has not yet occurred. The MTFM supports eleven NICE-approved and cost-saving devices, diagnostics, and digital products, making them mandatory for implementation and funding.

30

Nov 2022

In November 2022, the National Board of Health and Welfare released the Swedish version of the NordDRG system to come into force in January 2023, including the list of DRG codes, names, and cost-weights. A total of 77 new DRGs will be implemented. Key new DRGs were introduced in cardiovascular, gastrointestinal, and endoscopy fields, also for breast reconstruction and bone-anchored hearing implants.

29

Nov 2022

On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced that sixteen applications for Innovation Funding of the new forms of care were accepted. These applications relate to the funding announcement of March 17, 2021. Most projects relate to interdisciplinary or cross-sectoral care and pathways.

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 19 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

Check our specific propositions for: Med Tech industry, IVD industry, Investors

Our services cover 19 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Switzerland and Turkey

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

In-vitro diagnostic tests

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more

Confidence in results

MTRC is ISO 9001:2015 certified organization (with the United Kingdom Accreditation Service, UKAS). We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • 3D conformal radiation therapy
  • Ablation of heart tissue for atrial fibrillation
  • Angioplasty of arteries of lower extremities for peripheral artery disease
  • Atherectomy for peripheral artery disease
  • Bariatric surgery
  • Biologic and synthetic skin substitutes
  • Brachytherapy
  • Breast reconstruction
  • Capsule endoscopy
  • Cardiac pacemakers
  • Cardiac resynchronization therapy
  • Cholecystectomy
  • Coronary artery bypass grafting
  • Coronary imaging and diagnostic procedures
  • Coronary percutaneous revascularization procedures
  • Deep brain stimulation
  • Diagnostic endoscopic procedures on the lower gastrointestinal tract
  • Diagnostic endoscopic procedures on the upper gastrointestinal tract
  • Endoscopic biliary procedures
  • Health apps
  • Hemodialysis for acute kidney injury
  • Hernia repair
  • Embolic Protection Devices during percutaneous cardiac procedures (PCI and TAVI)
  • Endovascular repair (EVAR) of abdominal aortic aneurysm (AAA)
  • Extra-corporeal membrane oxygenation (ECMO) for pulmonary and cardiac failure
  • Image-guided radiotherapy
  • Implantable cardioverter defibrillators (ICDs)
  • Intensity modulated radiotherapy (IMRT)
  • Left atrial appendage occlusion
  • Mechanical ventilzation
  • Mechanical thrombectomy for acute ischemic stroke
  • Minimally-invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Open replacement of heart valves (all valves)
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
  • Percutaneous procedures for deep vein thrombosis
  • Proton Therapy
  • Robotic surgery interventions
  • Selective internal radiation therapy (SIRT)
  • Spinal cord stimulation
  • Stereotactic body radiation therapy
  • Stereotactic Radiosurgery
  • Surgical and endovascular treatment of brain aneurysm
  • Transcatheter aortic valve implantation (TAVI)
  • Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
  • Use of intra-aortic balloon pump (myocardial infarction and unstable angina, complicated by cardiogenic shock)
  • Vascular access for long-term use: AV fistula and AV graft
  • Ventricular assist devices for circulatory support
  • Volumetric modulated arc therapy (VMAT)

Ongoing reports:

  • Companion diagnostic tests for breast cancer
  • Biologic and synthetic skin substitutes